Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...

Please provide your email address to receive an email when new articles are posted on . Tivozanib induced a significantly higher disease control rate than sorafenib among patients with relapsed or ...

The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...

Over 100 million Americans currently live with high blood pressure, yet many remain unaware of its profound connection to kidney health. This relationship represents one of medicine’s most critical ...

Editor’s note: The National Kidney Foundation sponsored a session on this topic at its 2012 Spring Clinical Meetings in National Harbor, Md. The moderators were George L. Bakris, MD, Professor of ...

Personalized neoantigen vaccines show promise in activating immune responses and controlling tumors in kidney cancer patients. A phase 1 trial demonstrated neoantigen-specific T-cell responses and ...

A new meta-analysis further supports the previously reported link between kidney stones and an increased risk for kidney ...